Healthcare >> Analyst Interviews >> September 29, 2003

Investment Opportunities In Drug Delivery: Gary Davis – Jesup & Lamont Securities

GARY B. DAVIS is a Managing Director and Senior Security Analyst at Jesup & Lamont Securities. He has been employed as an Equity Analyst for 17 years and joined Jesup & Lamont in 1992. Since joining the firm, he has exclusively followed small healthcare companies, with a special emphasis on biotechnology, drug delivery, diagnostics and medical device companies. Prior to Jesup & Lamont, he worked at Rich & Co., Rosenkrantz, Lyon & Ross, Arnhold & S. Bleichroeder, and the Fourteen Research Corporation. He received his BA from Colgate University and his MBA from New York University. Profile
TWST: What is the investment focus for Jesup & Lamont Securities?

Mr. Davis: We're a boutique firm that specializes in growth companies,

primarily companies in the healthcare/life sciences